148 related articles for article (PubMed ID: 20541785)
21. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
[TBL] [Abstract][Full Text] [Related]
22. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
[TBL] [Abstract][Full Text] [Related]
23. The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy.
Huang X; Qian W; El-Sayed IH; El-Sayed MA
Lasers Surg Med; 2007 Oct; 39(9):747-53. PubMed ID: 17960762
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy.
Melancon MP; Lu W; Yang Z; Zhang R; Cheng Z; Elliot AM; Stafford J; Olson T; Zhang JZ; Li C
Mol Cancer Ther; 2008 Jun; 7(6):1730-9. PubMed ID: 18566244
[TBL] [Abstract][Full Text] [Related]
25. Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation.
Brockhoff G; Heckel B; Schmidt-Bruecken E; Plander M; Hofstaedter F; Vollmann A; Diermeier S
Cell Prolif; 2007 Aug; 40(4):488-507. PubMed ID: 17635517
[TBL] [Abstract][Full Text] [Related]
26. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles.
Cardinal J; Klune JR; Chory E; Jeyabalan G; Kanzius JS; Nalesnik M; Geller DA
Surgery; 2008 Aug; 144(2):125-32. PubMed ID: 18656617
[TBL] [Abstract][Full Text] [Related]
28. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
[TBL] [Abstract][Full Text] [Related]
29. Optical and electron microscopy study of laser-based intracellular molecule delivery using peptide-conjugated photodispersible gold nanoparticle agglomerates.
Krawinkel J; Richter U; Torres-Mapa ML; Westermann M; Gamrad L; Rehbock C; Barcikowski S; Heisterkamp A
J Nanobiotechnology; 2016 Jan; 14():2. PubMed ID: 26745990
[TBL] [Abstract][Full Text] [Related]
30. Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation.
García-Fernández L; Garcia-Pardo J; Tort O; Prior I; Brust M; Casals E; Lorenzo J; Puntes VF
Nanoscale; 2017 May; 9(18):6111-6121. PubMed ID: 28447703
[TBL] [Abstract][Full Text] [Related]
31. Surface plasmon resonance-induced photoactivation of gold nanoparticles as mitochondria-targeted therapeutic agents for pancreatic cancer.
Mocan L; Ilie I; Tabaran FA; Dana B; Zaharie F; Zdrehus C; Puia C; Mocan T; Muntean V; Teodora P; Ofelia M; Marcel T; Iancu C
Expert Opin Ther Targets; 2013 Dec; 17(12):1383-93. PubMed ID: 24188208
[TBL] [Abstract][Full Text] [Related]
32. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
[TBL] [Abstract][Full Text] [Related]
33. Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells.
Löw K; Wacker M; Wagner S; Langer K; von Briesen H
Nanomedicine; 2011 Aug; 7(4):454-63. PubMed ID: 21215330
[TBL] [Abstract][Full Text] [Related]
34. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.
Ping Li W; Meyer LA; Capretto DA; Sherman CD; Anderson CJ
Cancer Biother Radiopharm; 2008 Apr; 23(2):158-71. PubMed ID: 18454685
[TBL] [Abstract][Full Text] [Related]
35. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
Obaid G; Chambrier I; Cook MJ; Russell DA
Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
[TBL] [Abstract][Full Text] [Related]
36. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid.
Beyk J; Tavakoli H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2199-2209. PubMed ID: 31309302
[TBL] [Abstract][Full Text] [Related]
37. Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles.
Huang X; Jain PK; El-Sayed IH; El-Sayed MA
Photochem Photobiol; 2006; 82(2):412-7. PubMed ID: 16613493
[TBL] [Abstract][Full Text] [Related]
38. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods.
Huang X; El-Sayed IH; Qian W; El-Sayed MA
J Am Chem Soc; 2006 Feb; 128(6):2115-20. PubMed ID: 16464114
[TBL] [Abstract][Full Text] [Related]
39. Comparative Effect Between Laser and Radiofrequency Heating of RGD-Gold Nanospheres on MCF7 Cell Viability.
Sánchez-Hernández L; Ferro-Flores G; Jiménez-Mancilla NP; Luna-Gutiérrez MA; Santos-Cuevas CL; Ocampo-García BE; Azorín-Vega E; Isaac-Olivé K
J Nanosci Nanotechnol; 2015 Dec; 15(12):9840-8. PubMed ID: 26682422
[TBL] [Abstract][Full Text] [Related]
40. Important factors for cell-membrane permeabilization by gold nanoparticles activated by nanosecond-laser irradiation.
Yao C; Rudnitzki F; Hüttmann G; Zhang Z; Rahmanzadeh R
Int J Nanomedicine; 2017; 12():5659-5672. PubMed ID: 28848345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
